Anna M. Granato

Meldola, 47014, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanoma.

Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 14, 2025

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial.

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial.

Journal: Journal of translational medicine
Published: January 28, 2025

Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products.

Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products.

Journal: Cytotherapy
Published: April 12, 2024

In vitro CAR-T cell killing: validation of the potency assay.

In vitro CAR-T cell killing: validation of the potency assay.

Journal: Cancer immunology, immunotherapy : CII
Published: April 11, 2024

First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).

First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).

Journal: Frontiers in immunology
Published: March 21, 2024

Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center.

Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center.

Journal: Vaccines
Published: May 13, 2022

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma.

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma.

Journal: Frontiers in immunology
Published: September 16, 2021

Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay.

Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay.

Journal: International journal of molecular sciences
Published: May 04, 2021

Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors.

Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors.

Journal: Frontiers in immunology
Published: July 15, 2019

Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.

Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.

Journal: International journal of molecular sciences
Published: January 31, 2019

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial).

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial).

Journal: BMJ open
Published: August 08, 2018

Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone.

Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone.

Journal: Cytotherapy
Published: October 16, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026